Home Covid News and Updates India will begin trials of two new drugs to treat Covid-19 as part of the WHO Solidarity Clinical Trials.

India will begin trials of two new drugs to treat Covid-19 as part of the WHO Solidarity Clinical Trials.

by Vaishali Sharma
Coronavirus

The WHO Solidarity PLUS experiment includes 52 nations, with India being one of them. The efficacy of another medicine, artesunate, which is used to treat severe malaria, is also being investigated by the Covid-19 research collaboration. This third medicine will be tested in several other nations.

This month, India will launch Solidarity PLUS, the next phase of the World Health Organization’s Solidarity trial, which will assess the efficacy of new medications in treating hospitalised patients with Covid-19.

Imatinib and Infliximab, two medications already in use for different illnesses, will be studied in the Indian trial. Imatinib is a drug that is used to treat cancer.

“The trials would most likely start as soon as we receive the medications,” a senior official said, adding that it probably be this month.

You may also like